As increased claudin-5 expression and paracellular permeability were observed in a murine model of temporal lobe epilepsy, the higher claudin-5 levels and improved BBB function post anti-osteopontin IgG therapy in the current study is correlative and needs detailed investigation. This evidence concerns the gene CLDN5 and temporal lobe epilepsy.